Summary
Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on February 17, 2011, to announce its financial results for the fourth quarter and full year ended December 31, 2010. This filing primarily serves as a vehicle to furnish the press release containing these financial details, rather than introducing new material events or business developments. Investors reviewing this report should understand that the core information regarding the company's performance, including revenue, expenses, and net income/loss for the period, is contained within the accompanying press release (Exhibit 99.1). The 8-K itself confirms the date of the announcement and the availability of this information, highlighting the company's ongoing reporting obligations.
Key Highlights
- 1Alnylam Pharmaceuticals announced its financial results for the fourth quarter and full year ended December 31, 2010.
- 2The announcement was made via a press release furnished as an exhibit to the Form 8-K.
- 3The filing confirms the date of the financial results announcement as February 17, 2011.
- 4The 8-K is primarily a notification of financial results, with the detailed data contained in the press release (Exhibit 99.1).
- 5This filing does not appear to contain any new material business developments or strategic shifts.
- 6The information furnished is not deemed 'filed' for Section 18 of the Exchange Act purposes, limiting liability for its content.
- 7Patricia L. Allen, VP of Finance and Treasurer, signed the report, indicating internal authorization of the financial disclosure.
Frequently Asked Questions
The main purpose of this Form 8-K filing is to officially announce and provide access to Alnylam Pharmaceuticals' financial results for the fourth quarter and full year ended December 31, 2010. The detailed financial information is presented in an accompanying press release furnished as Exhibit 99.1.
The detailed financial results are provided in the press release dated February 17, 2011, which is included as Exhibit 99.1 to this Form 8-K filing. Investors should refer to this exhibit for the specific financial data.
Based on the provided filing, this Form 8-K primarily focuses on reporting financial results. It does not appear to disclose any new strategic initiatives or major business updates; those would typically be found in other sections of an 8-K or in different types of SEC filings.
When information is 'furnished' under Item 2.02 of an 8-K, it means the company is providing the information to the SEC but it is not subject to the same liability provisions as 'filed' information under Section 18 of the Securities Exchange Act of 1934. This is a common practice for earnings releases.